Synektik Spólka Akcyjna (SNT.WA)
PLN 184.4
(-1.91%)
PLN 184.4
(-1.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 125.43 Million PLN | 50.61% |
| 2023 | 83.28 Million PLN | 340.04% |
| 2022 | 26.47 Million PLN | 2.94% |
| 2021 | 18 Million PLN | -0.36% |
| 2020 | 18.07 Million PLN | 4.64% |
| 2019 | 17.8 Million PLN | 84.15% |
| 2018 | 11.42 Million PLN | 59.3% |
| 2017 | 7.92 Million PLN | 44.47% |
| 2016 | 4.35 Million PLN | 13.06% |
| 2015 | 3.66 Million PLN | -60.88% |
| 2014 | 8.97 Million PLN | -30.33% |
| 2013 | 13.7 Million PLN | 325.71% |
| 2012 | 3.2 Million PLN | 857.23% |
| 2011 | -416.15 Thousand PLN | -120.32% |
| 2010 | 2.16 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 49.42 Million PLN | 91.45% |
| 2024 Q3 | 24.48 Million PLN | 24.53% |
| 2024 Q2 | 20.87 Million PLN | -60.22% |
| 2023 Q2 | 8.23 Million PLN | -70.99% |
| 2023 Q4 | 28.14 Million PLN | 15.97% |
| 2023 FY | - PLN | 340.04% |
| 2023 Q3 | 24.27 Million PLN | 194.76% |
| 2023 Q1 | 28.38 Million PLN | 431.69% |
| 2022 Q2 | 9.33 Million PLN | 110.16% |
| 2022 Q4 | 5.33 Million PLN | -6.59% |
| 2022 FY | - PLN | 2.94% |
| 2022 Q1 | 4.44 Million PLN | -24.18% |
| 2022 Q3 | 5.71 Million PLN | -38.77% |
| 2021 Q3 | 1.68 Million PLN | -64.16% |
| 2021 Q2 | 4.7 Million PLN | -26.75% |
| 2021 Q1 | 6.42 Million PLN | 24.25% |
| 2021 FY | - PLN | -0.36% |
| 2021 Q4 | 5.85 Million PLN | 247.25% |
| 2020 FY | - PLN | 4.64% |
| 2020 Q4 | 5.17 Million PLN | 63.51% |
| 2020 Q1 | 5 Million PLN | 238.33% |
| 2020 Q2 | 4.66 Million PLN | -6.88% |
| 2020 Q3 | 3.16 Million PLN | -32.17% |
| 2019 Q1 | 11.87 Million PLN | 413.55% |
| 2019 FY | - PLN | 84.15% |
| 2019 Q4 | 1.48 Million PLN | -4.7% |
| 2019 Q3 | 1.55 Million PLN | -42.8% |
| 2019 Q2 | 2.71 Million PLN | -77.13% |
| 2018 Q3 | -149.5 Thousand PLN | -116.24% |
| 2018 FY | - PLN | 59.3% |
| 2018 Q1 | 4.69 Million PLN | 265.45% |
| 2018 Q2 | 920.34 Thousand PLN | -80.4% |
| 2018 Q4 | 2.31 Million PLN | 1646.84% |
| 2017 FY | - PLN | 44.47% |
| 2017 Q1 | 1.65 Million PLN | 43.28% |
| 2017 Q2 | 838.61 Thousand PLN | -49.44% |
| 2017 Q3 | 1.08 Million PLN | 29.96% |
| 2017 Q4 | 1.28 Million PLN | 17.9% |
| 2016 Q1 | 1.63 Million PLN | -50.5% |
| 2016 Q4 | 1.15 Million PLN | 11.5% |
| 2016 Q3 | 1.03 Million PLN | 74.99% |
| 2016 Q2 | 593.28 Thousand PLN | -63.62% |
| 2016 FY | - PLN | 13.06% |
| 2015 Q1 | 3.89 Million PLN | 62.4% |
| 2015 FY | - PLN | -60.88% |
| 2015 Q2 | 317.74 Thousand PLN | -91.85% |
| 2015 Q4 | 3.29 Million PLN | 308.29% |
| 2015 Q3 | -1.58 Million PLN | -597.81% |
| 2014 Q2 | 1.1 Million PLN | -83.56% |
| 2014 Q1 | 6.7 Million PLN | 61.52% |
| 2014 Q3 | 1.79 Million PLN | 63.16% |
| 2014 Q4 | 2.4 Million PLN | 33.43% |
| 2014 FY | - PLN | -30.33% |
| 2013 Q2 | 1.04 Million PLN | -71.49% |
| 2013 Q4 | 4.15 Million PLN | 143.15% |
| 2013 FY | - PLN | 325.71% |
| 2013 Q3 | 1.7 Million PLN | 63.55% |
| 2013 Q1 | 3.66 Million PLN | 699.14% |
| 2012 Q3 | 108.58 Thousand PLN | 110.51% |
| 2012 Q4 | 458.38 Thousand PLN | 322.16% |
| 2012 Q2 | -1.03 Million PLN | 0.0% |
| 2012 FY | - PLN | 857.23% |
| 2011 FY | - PLN | -120.32% |
| 2010 FY | - PLN | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Adiuvo Investments S.A. | -5.08 Million PLN | 2566.747% |
| Genomtec S.A. | -7.75 Million PLN | 1717.253% |
| Medinice S.A. | -4.72 Million PLN | 2753.567% |
| Medicalgorithmics S.A. | 2.23 Million PLN | -5512.264% |